Navigation Links
Terminally Ill Cancer Patients Are Not Getting Cash Benefits

A public accounts committee report says that many terminally ill cancer patients in the UK are missing out on cash benefits that could help them tide over financial difficulties related to their treatment costs. // The repots says that more than three quarters of cancer patients are not aware of the benefits that they are entitled to.

This means that they are missing out on £200 million each year. "Terminally ill patients are entitled to financial support or some financial support, which I, myself, was not aware of, but apparently three quarters of them are not told about it either, so this is quite clearly a very serious situation," said Edward Leigh, chairman of the Public accounts committee. "These people who are dying, they've got to be told that if they are in financial difficulties they needn't worry, because there is financial help available." Many charities are outraged at this situation and are calling on the government to rectify it, "Nobody has picked up the ball and taken responsibility for it and somebody must," said a spokesman for Macmillan Cancer Relief. The Commons spending watchdog also said that the money could go towards meeting the funeral expenses that burden the families. "I hope that through legislation - the Health Bill before Parliament now - we get a measure which ensures that where terminally ill patients are known to the health service," said Conservative health spokesman Andrew Lansley.
'"/>




Page: 1

Related medicine news :

1. Terminally Ill Patients Could Be Offered A Better Life
2. Terminally Ill deserves a better quality of Life
3. Terminally Ill Children Require Home Care
4. Terminally Ill: End Of Life Choices
5. Report Calls For Better Implementation Of Last Wishes of Terminally Ill
6. Terminally Ill Patients Asked To Depute People To Make Decisions
7. Fibroids unlikely to Turn Cancerous
8. Virus Level could Predict Cervical Cancer Risk
9. Cancer Doctors Okays Controversial Prostate Therapy
10. Potential New Cancer Gene Identified
11. Consensus on "Combination Therapy" for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... AWARE: A Week of Addiction and Recovery Education, from April 24 to April ... preventing substance use disorders. , The mission of AWARE is to instill ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... Worcestershire, UK (PRWEB) , ... April 21, 2017 ... ... Award for Enterprise in the category of International Trade, the UK’s most prestigious ... in international trade, which represents 95% of total revenues and has grown by ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
Breaking Medicine Technology: